Efficacy and toxicity profile of pegylated liposomal doxorubicin in patients with advanced ovarian cancer.
about
Toxicities of different first-line chemotherapy regimens in the treatment of advanced ovarian cancer: A network meta-analysis.The efficacy and safety of pegylated liposomal doxorubicin monotherapy and combination therapy with carboplatin in Korean patients with recurrent ovarian, fallopian tube, or primary peritoneal cancer: a single-institution experience.Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents.
P2860
Efficacy and toxicity profile of pegylated liposomal doxorubicin in patients with advanced ovarian cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Efficacy and toxicity profile ...... with advanced ovarian cancer.
@en
type
label
Efficacy and toxicity profile ...... with advanced ovarian cancer.
@en
prefLabel
Efficacy and toxicity profile ...... with advanced ovarian cancer.
@en
P2093
P2860
P1476
Efficacy and toxicity profile ...... with advanced ovarian cancer.
@en
P2093
Christine Mayer
Christof Sohn
Christoph Domschke
Florian Schuetz
Janina Brucker
Joachim Rom
Markus Wallwiener
Michael Golatta
Sarah Bechstein
P2860
P2888
P304
P356
10.1007/S00404-015-3913-9
P577
2015-10-26T00:00:00Z